Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum

Brain Research

Volumn 995, Issue 1, 2004, Pages 14-22

  Meredith, G E ^a   Switzer III, R C ^b   Napier, T C ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b NeuroScience Associates   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Brain derived neurotrophic factor; Eticlopride; Haloperidol; Neuroleptic; Plasticity; Quinpirole

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ETICLOPRIDE; HALOPERIDOL; NEUROLEPTIC AGENT; QUINPIROLE; SALICYLAMIDE DERIVATIVE; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; DOPAMINE RECEPTOR BLOCKING; DRUG ADMINISTRATION; DRUG EFFECT; DRUG EFFICACY; DYSKINESIA; ELECTRON MICROSCOPY; FOREBRAIN; GLOBUS PALLIDUS; HISTOLOGY; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; METABOLISM; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; OPTICAL DENSITY; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; SHORT COURSE THERAPY; SYNAPSE; SYNAPTIC TRANSMISSION; SYNAPTOSOME; ULTRASTRUCTURE;

EID: 0345303777     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.09.040     Document Type: Article

References (59)

1. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860.
2. Baldessarini R.J., Tarsy D. Pathophysiologic basis of tardive dyskinesia. Adv. Biochem. Psychopharmacol. 24:1980;451-455.
3. Bellows E.P., Barnes D.E., Csernansky J.G. Estimation of haloperidol concentrations in rat striatum after chronic treatment. Brain Res. Bull. 26:1991;715-719.
4. Black I.B. Trophic regulation of synaptic plasticity. J. Neurobiol. 41:1999;108-118.
5. Causing C.G., Gloster A., Alyz R., BamjI S.X., Change E., Fawcett J., Kuchel G., Miller F.D. Synaptic innervation density is regulated by neuron-derived BDNF. Neuron. 18:1997;257-267.
6. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17:1997;2295-2313.
7. Dawson N.M., Hamid E., Egan M.F., Meredith G.E. Haloperidol regulation of brain-derived neurotrophic factor in the extended amygdala of the rat. Synapse. 30:2001;70-81.
8. de Olmos J.S., Beltramino C.A., de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol. Teratol. 16:1994;545-561.
9. Depue R.A., Collins P.F. Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav. Brain Sci. 22:1999;491-517.
10. De Souza I.A.J., Meredith G.E. NMDA receptor blockade attenuates the haloperidol induction of Fos immunoreactivity in the dorsal but not the ventral striatum. Synapse. 32:1999;243-253.
11. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain: IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180:1978;545-580.
12. Figurov A., Pozzo-Miller L.D., Olafsson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature. 381:1996;706-709.
13. Fuller T.A., Russchen F.T., Price J.L. Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region. J. Comp. Neurol. 258:1987;317-338.
14. Gong W., Neill D.B., Justice J.B. Jr. GABAergic modulation of ventral pallidal dopamine release studied by in vivo microdialysis in the freely moving rat. Synapse. 29:1998;406-412.
15. Gong W., Neill D.B., Lynn M., Justice J.B. Jr. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience. 93:1999;1349-1358.
16. 2 receptors in the rat brain. Eur. J. Pharmacol. 111:1985;191-199.
17. Heidenreich B.A., Mailman R.B., Nichols D.E., Napier T.C. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine. J. Pharmacol. Exp. Ther. 273:1995;516-525.
18. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
19. Hyman C., Hofer Y.-A., Barde M., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
20. Johnson P.I., Napier T.C. GABA- and glutamate-evoked responses in the rat ventral pallidum are modulated by dopamine. Eur. J. Neurosci. 9:1997;1397-1406.
21. Jovanovic J.N., Benfenati F., Siow Y.L., Sihra T.S., Sanghera J.S., Pelech S.L., Greengard P., Czernik A. Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3679-3683.
22. Joyce J.N., Gurevich E.U. D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics. McGinty J.F. Advancing from the Ventral Striatum to the Extended Amygdala. vol. 877:1999;595-613 New York Academy of Sciences, New York.
23. Khot V., DeVane C.L., Korpi E.F., Venable D., Bigelow L.B., Wyatt R.J., Kirch D.G. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics. J. Clin. Psychopharmacol. 13:1993;120-127.
24. Klitenick M.A., Deutch A.Y., Churchill L., Kalivas P.W. Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience. 50:1992;371-386.
25. Korte M., Griesbeck O., Gravel C., Carroll P., Staiger V., Thoenen H., Bonhoeffer T. Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92:1996;8856-8860.
26. Lavin A., Grace A.A. Response of the ventral pallidal/mediodorsal thalamic system to antipsychotic drug administration: involvement of the prefrontal cortex. Neuropsychopharmacology. 18:1998;352-363.
27. Levinson A.J., Garside S., Rosebush P.I., Mazurek M.F. Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in the substantia nigra but not ventral tegmental area in the rat. Neuroscience. 84:1998;201-211.
28. Linder J.C., Young S.J., Groves P.M. Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem. Int. 26:1995;195-202.
29. Martinez-Murillo R., Semenenko F., Cuello A.C. The origin of tyrosine hydroxylase-immunoreactive fibers in the regions of the nucleus basalis magnocellularis of the rat. Brain Res. 45:1988;227-236.
30. Maslowski R.J., Napier T.C. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons. Eur. J. Pharmacol. 200:1991;103-112.
31. Maslowski-Cobuzzi R.J., Napier T.C. Activation of dopaminergic neurons modulates ventral pallidal responses evoked by amygdala stimulation. Neuroscience. 62:1994;1103-1120.
32. Mengual E., Pickel V.M. Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse. 43:2002;151-162.
33. 5enkephalin-immunoreactive synaptic boutons in the rat neostriatum after haloperidol decanoate treatment. Eur. J. Neurosci. 8:1996;716-726.
34. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78:1998;189-225.
35. Mitrovic I., Napier T.C. Substance P attenuates and DAMGO potentiates amygdala glutamatergic neurotransmission within the ventral pallidum. Brain Res. 792:1998;193-206.
36. Mitrovic I., Napier T.C. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur. J. Neurosci. 15:2002;257-268.
37. Mogenson G.J., Yang C.R. The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Napier T.C., Kalivas P.W., Hanin I. The Basal Forebrain: Anatomy to Function. 1991;267-290 Plenum, New York.
38. Napier T.C. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists. Synapse. 10:1992;110-119.
39. Napier T.C. Transmitter actions and interactions on pallidal neuronal function. Kalivas P.W., Barnes C.D. Limbic Motor Circuits and Neuropsychiatry. 1993;125-153 CRC Press, Boca Raton.
40. Napier T.C., Maslowski-Cobuzzi R.J. Electrophysiological verification for the presence of D1 and D2 dopamine receptors within the ventral pallidum. Synapse. 17:1994;160-166.
41. Napier T.C., Potter P.E. Dopamine in the rat ventral pallidum/substantia innominata: biochemical and electrophysiological studies. Neuropharmacology. 1989;757-760.
42. Napier T.C., Rehman F. Motoric analysis of dopamine receptor subtype activation within the ventral pallidum and dorsal globus pallidus. Proc. Soc. Neurosci. 18:1992;994.
43. Napier T.C., Simson P.E., Givens B.S. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. J. Pharmacol. Exp. Ther. 258:1991;249-262.
44. Napier T.C., Muench M.B., Maslowski R.J., Battaglia G. Is dopamine a neurotransmitter within the ventral pallidum/substantia innominata. Napier T.C., Kalivas P.W., Hanin I. The Basal Forebrain: Anatomy to Function. 1991;183-195 Plenum, New York.
45. Patterson S.L., Abel T., Deuel T.A.S., Martin K.C., Rose J.C., Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 16:1996;1137-1145.
46. Ricardo J.A. Efferent connections of the subthalamic region in the rat: I. The subthalamic nucleus of Luys. Brain Res. 202:1980;257-271.
47. Richfield E.K., Penney J.B., Young A.B. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience. 30:1989;767-777.
48. Riedel A., Hartig W., Seeger G., Gartner U., Brauer K., Arendt T. Principles of rat subcortical forebrain organization: a study using histological techniques and multiple fluorescence labeling. J. Chem. Neuroanat. 23:2002;75-104.
49. Rutherford L.C., DeWan A., Lauer H.M., Turrigiano G.G. Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures. J. Neurosci. 17:1997;4527-4535.
50. Seeman P., Grigoriadis D. Dopamine receptors in brain and periphery. Neurochem. Int. 10:1987;1-25.
51. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290:1989;213-242.
52. Shults C.W., Kimber T., Altar C.A. BDNF attenuates the effect of intrastriatal injection of 6-hydroxydopamine. NeuroReport. 6:1995;1109-1112.
53. Sizemore G.M., Co C., Smith J.E. Ventral pallidal extracellular fluid levels of dopamine, serotonin, gamma aminobutyric acid, and glutamate during cocaine self-administration in rats. Psychopharmacology. 150:2000;391-398.
54. Switzer R.C. Application of silver degeneration stains for neurotoxicity testing. Toxicol. Pathol. 28:2000;70-83.
55. Turner M.S., Lavin A., Grace A.A., Napier T.C. Regulation of limbic information outflow by the subthalamic nucleus: excitatory amino acid projections to the ventral pallidum. J. Neurosci. 21:2001;2820-2832.
56. Turner M.S., Mignon L., Napier T.C. Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion. J. Pharmacol. Exp. Ther. 301:2002;371-381.
57. Voorn P., Jorritsma-Byham B., Van Dijk C., Buijs R.M. The dopaminergic innervation of the ventral striatum in the rat: a light- and electron-microscopical study with antibodies against dopamine. J. Comp. Neurol. 251:1986;84-99.
58. Wright A.M., Bempong J., Kirby M.L., Barlow R.L., Bloomquist J.R. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia. Brain Res. 788:1998;215-222.
59. Zaborszky L., Duque A. Local synaptic connections of basal forebrain neurons. Behav. Brain Res. 115:2000;143-158.